Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07110857

Evaluation of the Superficial Cervical Plexus Block in Oncological Throat and Neck Surgery

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
346 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This national, prospective, multicenter, randomized study aims to reduce the amount of intravenous morphine (titration + PCA morphine) during the first 24 postoperative hours via a locoregional anesthesia technique in patients undergoing throat and neck cancer surgery.

Detailed description

The incidence of throat and neck (ENT) cancers is 15000 new cases/year in France. Nowadays, there are no studies with a sufficient level of evidence to establish formal recommendations on analgesic treatments to be applied in the context of ENT cancer surgery. As cancer surgery causes severe acute postoperative pain and chronic pain, loco-regional anesthesia (LRA) plays an increasingly role in the prevention of this type of pain. However, nowadays there is no data in the literature highlighting the interest of LRA in the context of ENT cancer surgery, despite a significant theoretical benefit. The superficial cervical block, already used in carotid or thyroid surgery, has already shown its value. It seems logical to propose this block in throat and neck cancer surgery.

Conditions

Interventions

TypeNameDescription
PROCEDURECervical plexus block with 0.2 % NaropeineUnder ultrasound guidance, a superficial cervical plexus block is performed immediately after induction and before skin incision by injecting 15-25 mL of 0.2 % ropivacaine (Naropeine) uni- or bilateral depending on the surgical incision
PROCEDURECervical plexus block with saline placeboUnder ultrasound guidance, a superficial cervical plexus block is performed immediately after induction and before skin incision by injecting 15-25 mL of 0.9 % saline uni- or bilateral depending on the surgical incision

Timeline

Start date
2025-09-01
Primary completion
2027-06-01
Completion
2027-09-01
First posted
2025-08-08
Last updated
2025-08-08

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT07110857. Inclusion in this directory is not an endorsement.